Literature DB >> 11804640

(-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions.

Guo-Zhang Jin1, Zi-Tao Zhu, Yu Fu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11804640     DOI： 10.1016/s0165-6147(00)01929-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  25 in total

Review 1.  l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.

Authors:  Jia Bei Wang; John R Mantsch
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.

Authors:  A Del Arco; F Mora; A H Mohammed; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

3.  Dissociable effects of the d- and l- enantiomers of govadine on the disruption of prepulse inhibition by MK-801 and apomorphine in male Long-Evans rats.

Authors:  Brittney R Lins; Wendie N Marks; Anthony G Phillips; John G Howland
Journal:  Psychopharmacology (Berl)       Date:  2017-02-08       Impact factor: 4.530

4.  (-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling.

Authors:  Julie A Meade; R Benjamin Free; Nicole R Miller; Lani S Chun; Trevor B Doyle; Amy E Moritz; Jennie L Conroy; Val J Watts; David R Sibley
Journal:  Psychopharmacology (Berl)       Date:  2014-09-18       Impact factor: 4.530

5.  Differential effect of isoflurane, medetomidine, and urethane on BOLD responses to acute levo-tetrahydropalmatine in the rat.

Authors:  Xiping Liu; Rupeng Li; Zheng Yang; Anthony G Hudetz; Shi-Jiang Li
Journal:  Magn Reson Med       Date:  2011-12-28       Impact factor: 4.668

6.  Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats.

Authors:  Callum Hicks; Peng Huang; Linnet Ramos; Sunil U Nayak; Yohanka Caro; Allen B Reitz; Garry R Smith; David Y-W Lee; Scott M Rawls; Lee-Yuan Liu-Chen
Journal:  ACS Chem Neurosci       Date:  2018-04-06       Impact factor: 4.418

Review 7.  Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction.

Authors:  Hongyuan Chu; Guozhang Jin; Eitan Friedman; Xuechu Zhen
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

8.  Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells.

Authors:  You He; Lei-Ping Yu; Guo-Zhang Jin
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

9.  Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D(1) and antagonist at D(2) receptors, in rats.

Authors:  Yan Sun; Jieyu Dai; Zheyi Hu; Feifei Du; Wei Niu; Fengqing Wang; Fei Liu; Guozhang Jin; Chuan Li
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

10.  The dopamine D1 receptor agonist and D2 receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats.

Authors:  Natasa Milivojevic; Igor Krisch; Dusan Sket; Marko Zivin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-07       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.